VF
TRAW icon

Virtu Financial’s Traws Pharma TRAW Stock Holding History

Virtu Financial’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+12,579
New +$17.3K ﹤0.01% 1433
2024
Q3 		– Sell
-1,094
Closed -$12K – 1968
2024
Q2 		$12K Buy
+1,094
New +$17.6K ﹤0.01% 1113
2023
Q1 		– Sell
-679
Closed -$11K – 2184
2022
Q4 		$11K Sell
679
-259
-28% -$4.88K ﹤0.01% 1372
2022
Q3 		$21K Buy
+938
New +$28.4K ﹤0.01% 1392
2022
Q1 		– Sell
-481
Closed -$31K – 2135
2021
Q4 		$31K Buy
+481
New +$38.7K ﹤0.01% 1443
2021
Q2 		– Sell
-2,232
Closed -$836K – 2157
2021
Q1 		$836K Buy
2,232
+939
+73% +$354K 0.06% 308
2020
Q4 		$226K Buy
1,293
+114
+10% +$13.2K 0.02% 784
2020
Q3 		$124K Buy
+1,179
New +$291K 0.02% 684
2018
Q3 		– Sell
-3
Closed -$7K – 2309
2018
Q2 		$7K Buy
+3
New +$8.71K ﹤0.01% 1914
2018
Q1 		– Sell
-2
Closed -$19K – 2718
2017
Q4 		$19K Sell
2
-4
-67% -$41.2K ﹤0.01% 2227
2017
Q3 		$55K Buy
+6
New +$62.1K ﹤0.01% 2213

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Virtu Financial's TRAW Position: Q2 2026 in Review

Virtu Financial opened a new position in Traws Pharma (TRAW) in Q2 2026: 12,579 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: Virtu Financial previously reported a position in TRAW as recently as Q2 2024.

Virtu Financial first reported a position in TRAW in Q3 2017 and has held it in 11 quarters since. The position peaked at $836K in Q1 2021. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Virtu Financial held 12,579 shares of Traws Pharma worth $11K as of Q2 2026.
  • Traws Pharma was a new Virtu Financial position in Q2 2026.
  • Traws Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1433 holding.
  • Virtu Financial first reported a position in Traws Pharma in Q3 2017 and has held it in 11 quarters since.
  • Virtu Financial's Traws Pharma position peaked at $836K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.